4.8 Article

A structural basis for amylin receptor phenotype

Journal

SCIENCE
Volume 375, Issue 6587, Pages 1371-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.abm9609

Keywords

-

Funding

  1. Monash University Ramaciotti Centre for Cryo-Electron Microscopy
  2. Monash MASSIVE high-performance
  3. National Institutes of Health [R01-GM129325]
  4. Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases
  5. Australian Research Council (ARC) [IC200100052]
  6. National Health and Medical Research Council of Australia (NHMRC) [1120919, 1159006, 1154434, 1155302]
  7. Victoria Endowment for Science Knowledge and Innovation
  8. Takeda Science Foundation
  9. Japan Science and Technology Agency (PRESTO) [18069571]
  10. National Health and Medical Research Council of Australia [1155302, 1120919, 1154434, 1159006] Funding Source: NHMRC
  11. Australian Research Council [IC200100052] Funding Source: Australian Research Council

Ask authors/readers for more resources

The structure and dynamics of AMYRs with amylin and CT were studied, revealing the role of RAMP and the presence of a bypass motif. The binding mechanism of CT-based peptides to AMYRs is distinct from that of amylin-based peptides. This finding has implications for the development of AMYR therapeutics.
Amylin receptors (AMYRs) are heterodimers of the calcitonin (CT) receptor (CTR) and one of three receptor activity-modifying proteins (RAMPs), AMY(1)R, AMY(2)R, and AMY(3)R. Selective AMYR agonists and dual AMYR/CTR agonists are being developed as obesity treatments; however, the molecular basis for peptide binding and selectivity is unknown. We determined the structure and dynamics of active AMYRs with amylin, AMY(1)R with salmon CT (sCT), AMY(2)R with sCT or human CT (hCT), and CTR with amylin, sCT, or hCT. The conformation of amylin-bound complexes was similar for all AMYRs, constrained by the RAMP, and an ordered midpeptide motif that we call the bypass motif. The CT-bound AMYR complexes were distinct, overlapping the CT-bound CTR complexes. Our findings indicate that activation of AMYRs by CT-based peptides is distinct from their activation by amylin-based peptides. This has important implications for the development of AMYR therapeutics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available